Protein A Resin Market, By Product (Agarose-Based Protein A, Glass/Silica-Based Protein A, Organic Polymer-Based Protein A), Application (Antibody Purification and Immunoprecipitation), End-User (Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes, Other End Users) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Global protein a resin market is anticipated to reach USD 1.3 billion in 2021 growing at a CAGR of 11.6% during the forecasting period, 2021-2028.
Protein A is a surface protein that is found in the cell walls of most of the staphylococcus aureus bacteria. It’s a type 1 surface protein. Protein A might be variable in different species of staphylococcus aureus but has the same purpose of interfering with the host B type immunity cell and prevent the phagocytosis and destruction of the bacteria. This protein is majorly used in biomanufacturing due to its high specificity toward the fragment crystallizable region (fc) of the monoclonal antibodies. Its specificity is used to isolate recombinant monoclonal antibodies and it can easily achieve a purity level where host cell protein reduces to less than 100ppm and DNA content to less than 10pg/dose. The commercial classification of Protein A is on the basis of its bead size, base matrix composition, pore size, etc. these features have a direct relation with the performance of the Protein A resin column. Due to its high costs, companies are researching for Protein A resin which could provide high binding ability at higher flow rates too.
The increasing need to avoid the laborious process has boosted the demand for pre-packed columns is one of the factors that have supported long-term expansion for the protein A resin industry.
Global protein a resin market is segmented into product, application, end-user, and geography.
Product segment is segmented into Agarose-Based Protein A, Glass/Silica-Based Protein A, and Organic Polymer-Based Protein A.
Application segment is segmented into Antibody Purification and Immunoprecipitation.
End-User segment is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes, and Other End Users.
Geographically, the global protein a resin market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America and insights are provided for each region and major countries within the regions
GE Healthcare (US), Repligen Corporation (US), Merck Millipore (Germany), are some of the leading players of the Protein A Resin market
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 1.3 billion |
Growth Rate |
CAGR of 11.6% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
Product, Application, End-User, and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US), Bio-Rad Laboratories (US), Orochem (US), Kaneka Corporation (Japan), Abcam (UK), Agarose Bead Technologies (US), Avantor (US), JSR Life Sciences (US), Bio-Works Technologies (Sweden), Amikozen Co. Ltd. (US), and Takara Bio Inc. (Japan) |
Available Customization |
In addition to the market data for protein a resin market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement |